Homepage
Author:
Optimum Strategic Communications
Posted Date:
January 29, 2026
Biocomposites launches SYNICEM™ spacers in Canada
Optimum Strategic Communications
January 29, 2026
TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development
Optimum Strategic Communications
January 29, 2026
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing
Optimum Strategic Communications
January 29, 2026
Resolve M Therapeutics exits from stealth
Optimum Strategic Communications
January 27, 2026
New Global Consortium Aims to Transform Antibiotic Discovery to Counter the Growing AMR Crisis
Optimum Strategic Communications
January 27, 2026
